↓ Skip to main content

Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far

Overview of attention for article published in OncoTargets and therapy, April 2023
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far
Published in
OncoTargets and therapy, April 2023
DOI 10.2147/ott.s379867
Pubmed ID
Authors

Stefania Stella, Federica Martorana, Michele Massimino, Silvia Rita Vitale, Livia Manzella, Paolo Vigneri

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 3 16%
Student > Bachelor 3 16%
Student > Ph. D. Student 2 11%
Researcher 2 11%
Student > Master 2 11%
Other 1 5%
Unknown 6 32%
Readers by discipline Count As %
Medicine and Dentistry 4 21%
Unspecified 3 16%
Biochemistry, Genetics and Molecular Biology 2 11%
Neuroscience 2 11%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Other 1 5%
Unknown 6 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 May 2023.
All research outputs
#20,905,193
of 26,560,982 outputs
Outputs from OncoTargets and therapy
#1,479
of 3,031 outputs
Outputs of similar age
#308,740
of 432,555 outputs
Outputs of similar age from OncoTargets and therapy
#8
of 13 outputs
Altmetric has tracked 26,560,982 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,031 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,555 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.